Quick Answer
Century Therapeutics, Inc. reported Total Revenue of $109.16 million for the year ending 2025.
- Century Therapeutics, Inc. showed an increase of +1,556.8% in Total Revenue from 2024 to 2025.
- This data is from Century Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $1.06 million | Q2 2022: $1.40 million | Q3 2022: $2.22 million | Q1 2023: $1.72 million | Q2 2023: $99.0 thousand | Q3 2023: $148.0 thousand | Q1 2024: $855.0 thousand | Q2 2024: $771.0 thousand | Q3 2024: $791.0 thousand | Q1 2025: $109.16 million.
- Over the full 4 years of available data (2022 to 2025), Century Therapeutics, Inc.'s Total Revenue has grown by 1,999.7%.
- Historical annual values: Fiscal year 2025: $109.16 million | Fiscal year 2024: $6.59 million | Fiscal year 2023: $2.24 million | Fiscal year 2022: $5.20 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: